Buda Juice Announces Full Exercise of Underwriters’ Over-Allotment Option in Connection with Initial Public Offering

Rhea-AI Summary

Buda Juice (NYSE American: BUDA) announced the underwriters fully exercised the 15% over-allotment in its initial public offering, adding 399,999 shares and bringing total shares sold to 3,066,666 at $7.50 per share for gross proceeds of approximately $23.0 million before fees. The offering has closed and BUDA began trading on January 8, 2026. The company said it is profitable and plans to use the capital to expand branded distribution, enter new markets and scale its white-label platform while marketing its UltraFresh™ cold-chain juice positioned in produce departments.

Positive

• Gross proceeds of $23.0 million
• Total of 3,066,666 shares sold at $7.50
• Underwriters exercised full 15% over-allotment
• Trading began Jan 8, 2026 on NYSE American

Negative

• Issued additional 399,999 shares via green shoe (15%)
• Gross proceeds reported before underwriting discounts and offering expenses

News Market Reaction – BUDA

+3.67%

1 alert

+3.67% News Effect

On the day this news was published, BUDA gained 3.67%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Over-allotment size: 399,999 shares Total IPO shares: 3,066,666 shares IPO price: $7.50 per share +5 more

8 metrics

Over-allotment size 399,999 shares Additional shares from 15% over-allotment option

Total IPO shares 3,066,666 shares Total common stock sold including over-allotment

IPO price $7.50 per share Public offering price for common stock

Gross proceeds $23.0 million Total IPO gross proceeds before fees and expenses

Over-allotment percentage 15% Underwriter’s over-allotment option size

Cold chain temperature 35°F Continuous cold chain from fruit to shelf

Shelf life 8–12 days Product shelf life under UltraFresh cold chain

Juice market size $55 billion Approximate annual U.S. juice and beverage market

Market Reality Check

Price: $8.36 Vol: Volume 33,618 is at 0.59x...

low vol

$8.36 Last Close

Volume Volume 33,618 is at 0.59x the 20-day average of 57,424, indicating subdued trading ahead of this announcement. low

Technical Shares at $8.44 are trading below the 200-day MA of $8.75 and sit 29.67% below the 52-week high of $12.00.

Market Pulse Summary

This announcement details the full exercise of the IPO over-allotment option, bringing total gross p...

Analysis

This announcement details the full exercise of the IPO over-allotment option, bringing total gross proceeds to $23.0 million on 3,066,666 shares at $7.50. It reinforces that the offering has closed and the company now holds additional capital to pursue its growth plans. Investors may focus on how effectively Buda scales distribution, maintains its 35°F cold chain, and leverages a reported $55 billion U.S. market.

Key Terms

over-allotment option, green shoe, cold chain, form s-1, +2 more

6 terms

over-allotment option financial

"has exercised in full its 15% over-allotment option, resulting in the issuance"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

green shoe financial

"IPO demand supported full “green shoe” exercise, increasing gross proceeds"

A green shoe is a provision in an initial or follow-on share offering that lets the firm managing the sale buy a limited extra percentage of shares (typically about 15%) from the issuer to meet extra demand or stabilize trading. It matters to investors because the extra shares can be added or removed to smooth price swings after the offering—like a thermostat adjusting supply—reducing early volatility and influencing short-term dilution and availability.

cold chain technical

"UltraFresh products through a continuous 35°F cold chain from fruit to shelf"

A cold chain is the continuous temperature-controlled system used to store and transport products that must stay cold, such as vaccines, biologic medicines, and some foods — think of a refrigerator on wheels and in warehouses that keeps items at specific temperatures from factory to customer. Investors watch cold chain strength because failures raise product loss, regulatory trouble, and extra costs, while reliable cold chains protect sales, margins, and a company’s reputation.

form s-1 regulatory

"A registration statement on Form S-1 (File No. 333-289874) (the “Registration"

A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.

registration statement regulatory

"A registration statement on Form S-1 (File No. 333-289874) (the “Registration"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

prospectus financial

"The Offering was made only by means of a prospectus, forming part of the"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. Not financial advice.

UltraFresh™ juice maker’s IPO demand supported full “green shoe” exercise, increasing gross proceeds to approximately $23.0 million

Dallas, TX, Jan. 22, 2026 (GLOBE NEWSWIRE) -- (NYSE American: BUDA), $BUDA, pioneer of the new UltraFresh™ juice category for the supermarket fresh produce department with its cold-crafted, UltraFresh™ citrus juices, today announced that the underwriter of its initial public offering (the “Offering”) has exercised in full its 15% over-allotment option, resulting in the issuance of an additional 399,999 shares of common stock. Including the over-allotment shares, Buda Juice sold a total of 3,066,666 shares of common stock at a public offering price of $7.50 per share, generating gross proceeds of approximately $23.0 million, before deducting underwriting discounts and offering expenses. The Offering has now closed. The Company’s shares began trading on the NYSE American exchange under the symbol “BUDA” on January 8, 2026.

Horatio Lonsdale-Hands, Chief Executive Officer and Co-Founder of Buda Juice, commented:

“The successful closing of our initial public offering, including the full exercise of the underwriters’ over-allotment option, marks a defining moment in Buda Juice’s evolution and reflects the confidence investors have in our UltraFresh platform, our disciplined operating model and the growing demand we see from both consumers and retail customers."

“We built Buda to solve a fundamental challenge in the beverage industry by delivering truly fresh juice at retail scale, and this milestone gives us the capital, visibility and flexibility to accelerate that vision. As a profitable business with a clear growth strategy, we are focused on extending our geographic reach, expanding our branded portfolio and scaling our white label platform in a way that we believe will drive sustainable, long term value creation for our shareholders. This milestone accelerates our ability to bring UltraFresh to more consumers, more retailers and more markets, and we believe it marks the beginning of a much larger growth story for Buda Juice.”

A Large Market Opportunity Ready for Disruption

Buda is addressing a large and growing opportunity within the U.S. juice and beverage market, which exceeds $55 billion annually. As consumers increasingly seek clean label, minimally processed products, the category has remained dominated by shelf stable and heavily processed offerings. Buda believes this disconnect has created a meaningful opportunity for a truly fresh alternative designed specifically for grocery retail environments.

With a proven, profitable operating model and strong retail validation, the Company believes it is well positioned to help redefine how fresh juice is produced, merchandised and scaled.

A Clear and Defensible Differentiation in Fresh

Compared with products that use pasteurization, expensive high-pressure processing or extended shelf-life techniques, Buda delivers UltraFresh products through a continuous 35°F cold chain from fruit to shelf. This approach preserves authentic taste and nutrient quality while providing an 8-to-12-day shelf life that fits seamlessly into existing retail distribution models.

Buda products are merchandised in the fresh produce section, where consumers already expect freshness and quality. Placement alongside fresh fruits and vegetables reinforces the UltraFresh positioning, engages health focused shoppers and allows retailers to leverage existing produce department infrastructure and labor. This strategic placement differentiates Buda Juice from traditional refrigerated and shelf stable beverages and supports strong product velocity without adding operational complexity.

Positioned for the Next Phase of Growth

With the completion of its initial public offering, Buda plans to accelerate its growth strategy by expanding distribution of its branded products, entering new geographic markets and scaling its white label platform with retail customers. Buda believes its UltraFresh cold chain platform provides a strong foundation to grow efficiently while maintaining the quality and freshness that define the brand.

MDB Capital acted as the underwriter of the offering.

A registration statement on Form S-1 (File No. 333-289874) (the “Registration Statement”) relating to these securities was filed with the Securities and Exchange Commission (the “SEC”) and was declared effective on January 7, 2026. The Offering was made only by means of a prospectus, forming part of the effective registration statement. A copy of the final prospectus related to and describing the terms of the Offering may be obtained from MDB Capital, 14135 Midway Road, Suite G-150, Addison, TX 75001, or via email at community@mdb.com or telephone at (945) 262-9010. In addition, the final prospectus relating to the Offering may be obtained via the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, any securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful.

About Buda Juice

Buda Juice is pioneering the UltraFresh juice category through an end-to-end cold chain platform that delivers always-cold, freshly crafted juices, lemonades, and wellness shots to grocery retailers. We provide a turnkey alternative to shelf-stable beverages and in-store juicing, enabling retailers to offer truly fresh, safe juice without added infrastructure or operational complexity. Our continuous 35°F cold chain from fruit to shelf delivers clean-label products with an 8 to 12-day shelf life that preserves authentic taste and nutrient quality while enabling efficient retail distribution.

Buda Juice is expanding its branded portfolio, entering new geographic markets and scaling a growing white-label platform that delivers meaningful cost savings and fresh category differentiation for retail customers.

Forward Looking Statements

This press release contains forward-looking statements. Forward-looking statements are not historical facts and include statements regarding the company’s plans, objectives, expectations and intentions. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking statements. Many such risks and uncertainties are beyond the control of the company, including those discussed in the Risk Factors section of the company’s registration statement for the initial public offering, which is available on the SEC’s website, www.sec.gov. The company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Investor/Press Contact:

Brian S. Siegel, IRC®, M.B.A.
Senior Managing Director
Hayden IR - Chicago
(346) 396-8696 (o)
brian@haydenir.com
www.haydenir.com

FAQ

How much did Buda Juice (BUDA) raise in its IPO after the over-allotment?

Including the full 15% over-allotment, BUDA generated approximately $23.0 million in gross proceeds before fees.

How many shares did BUDA sell in the offering and at what price?

BUDA sold a total of 3,066,666 shares at a public offering price of $7.50 per share.

What is the over-allotment (green shoe) detail for BUDA's IPO?

The underwriter exercised the full 15% over-allotment, resulting in an additional 399,999 shares issued.

When did BUDA start trading on the NYSE American exchange?

BUDA began trading on the NYSE American exchange under the symbol BUDA on January 8, 2026.

What will Buda Juice use the IPO proceeds for?

Buda plans to use the capital to expand branded distribution, enter new geographic markets and scale its white-label platform.

Who acted as underwriter for Buda Juice's offering and where can the prospectus be obtained?

MDB Capital acted as the underwriter; the final prospectus is available from MDB Capital or via the SEC website.